NCT03054948View on ClinicalTrials.gov

SMOFLipid in Patients Who Are Intralipid Intolerant

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 1, 2017

Primary Completion Date

March 20, 2018

Study Completion Date

March 20, 2018

Conditions
Home Parenteral NutritionShort Bowel Syndrome
Interventions
DRUG

SMOFLipid

SMOFlipid is a lipid emulsion formed using soybean oil, medium chain triglycerides, olive oil, and fish oil.

DRUG

Standard therapy

In most cases standard therapy will be IntraLipid.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER